NJ tax dollars spent on ‘Blue Ribbon’ school awards that critics call deceptive
Julie O’Connor, NJ Spotlight News
Bellyard Partners, LLC et al. v. Falfurrias Capital Partners, LP and Global Plasma Solutions, Inc.
24-cv-4128, N.D. Ga.
(Sept. 2024)
Products with Needlepoint Bipolar Ionization technology, including GPS-FC48-AC, GPS-FC24-AC, and others
Falsely representing that products eliminate the COVID-19 virus and produce cleaner air
Falsely representing that claims are based on independent testing when the company paid for the testing and the products do not achieve the same results in real world conditions
Pending
Julie O’Connor, NJ Spotlight News
Sara Talpos, Med Shadow
Ingredient claims come into the limelight.
Beware of food images wrapped in deception.
The DSA misses the mark.